Neutrophil-to-lymphocyte ratio as a sensitive marker in diagnosis of celiac disease

Murat Sarikaya, Zeynal Dogan, Bilal Ergul, Levent Filik

Ankara Education and Research Hospital, Ankara, Turkey


Gastroenterology Department, Ankara Education and Research Hospital, Ankara, Turkey
Correspondence to: Dr. Levent Filik, Ankara Education and Research Hospital, Gastroenterology Department, Ulucanlar, Altındağ, Ankara, TR 06230, Turkey, e-mail: leventfilik@yahoo.co.uk
Received 30 April 2014; accepted 25 May 2014
© 2014 Hellenic Society of Gastroenterology


Celiac disease (CD) is a small intestinal mucosal disease leading to malabsorbtion due to inflammatory reaction to gluten [1-4]. CD has a prevelance of approximately 1% of the population. But, it is estimated that up to 90% are undiagnosed due to subclinical presentations [5]. Also, diverse clinical manifestations can lead to delays in diagnosis [4]. Laboratory indices and biomarkers used in daily general medical practice are important in detecting new cases of CD, otherwise a delayed diagnosis can lead to development of important complications such as osteoporosis [6-9]. Neutrophil-to-lymphocyte ratio (NLR) was introduced as a useful index for diagnosis or prognosis of different diseases [7]. We hypothesized that NLR might change in patients with CD as an inflammatory disease. Blood count changes such as anemia, leukopenia are well-known but there is no data for NLR in CD [8,9]. In this regard, we prospectively checked the diagnostic role of the NLR in 76 patients with CD (M:26, F:50) at the time of diagnosis. Diagnosis of study patients was based on celiac antibodies (anti-gliadin, anti-endomysium and tissue transglutaminase), and duodenal biopsy [1,10]. Eighty-six patients with functional dyspepsia (M:33, F:53), all of whom had a normal complete blood cell count, C-reactive protein (CRP), and negative serology for anti-gliadin and anti-endomysium antibodies were recruited as control group. Statistical analyses were performed using SPSS version 17.0. Chi-square test was used for comparison of categorical variables. A P-value <0.05 was considered statistically significant. The Receiver Operating Characteristics (ROC) curve analysis was carried out to indicate the sensivity and specifity of NLR and its respective optimal cut-off value for predicting CD. Mean ages of groups were 38.5±12.11 years in CD patients and 36.5±12.2 years in controls (P>0.05). NLR was significantly higher in patients with CD (2.42±1.24) when compared to control group (1.92±0.58) (P<0.019). The success of NLR in diagnosing CD was statistically remarkable when tested with ROC analysis (Fig. 1). The cut-off value of NLR was 2.32. According to this cut-off value, sensitivity was 80% and specificity 41%.

Figure 1

The receiver-operating characteristic curve of neutrophil-to- lymphocyte ratio for predicting celiac disease

thumblarge

Neutrophils and lymphocytes are the cells that play a major role in inflammatory processes. Therefore, counts of neutrophils and lymphocytes temporarily change in inflammation. Cellular immunity obviously plays a major role in intestinal damage in CD [1,2,8]. The main pathogenesis of CD is believed to be related to a gluten-specific T-lymphocyte-mediated response resulting in an overexpression of interferon-γ in the epithelial compartment [1]. Inflammation is not confined to duodenum but also involves other gastrointestinal mucosa. Accordingly, surface lymphocytic infiltration of the stomach and colon can also be seen [9]. NLR change seems to be linked with this inflammation and cytokines. In conclusion, NLR might be used as a sensitive laboratory index in screening and diagnosis of CD.

References

1. Ciclitira PJ. Recent advances in coeliac disease. Clin Med 2003;3:166-169.

2. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ. Antiendomysium and antigliadin antibodies in untreated celiacs: disappointing in clinical practice. Am J Gastroenterol 1999;94:888-894.

3. Dickey W, McMillan SA, Hughes DF. Sensitivity of serum tissue transglutaminase antibodies for endomysial antibody positive and negative coeliac disease. Scand J Gastroenterol 2001;36:511-514.

4. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137:88-93.

5. Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007;26:1217-1225.

6. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG Clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656-676.

7. Motomura T, Shirabe K, Mano Y, et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol 2013;58:58-64.

8. Halfdanarson TR, Litzow MR, Murray JA. Hematologic manifestations of celiac disease. Blood 2007;109:412-421.

9. See J, Murray JA. Gluten-free diet: the medical and nutrition management of celiac disease. Nutr Clin Pract 2006;21:1-15.

10. Marsh MN. Studies of intestinal lymphoid tissue. XI-The immunopathology of cell-mediated reactions in gluten sensitivity and other enteropathies. Scanning Microsc 1988;2:1663-1684.

Notes

Conflict of Interest: None